Intellia (NTLA) Inks Deal With Kyverna for Autoimmune Diseases

Published on January 6, 2022

Intellia (NTLA) inks a licensing and collaboration deal with Kyverna Therapeutics for developing an allogeneic CAR T-cell therapy for autoimmune diseases.

Continue reading on website
Other news

The Cloud Kitchen Industry: Revolutionizing Traditional Restaurants for Evolving, New-Age Consumer Needs

January 6, 2022
Businesses, particularly dine-in restaurants, are struggling worldwide, and this now seems to be the new normal. It is a fact that unprecedented challenges trigger innovation; cloud kitchens are one such...

FTI Consulting (FCN) Announces Appointments of Senior Officials

January 6, 2022
FTI Consulting (FCN) welcomes Guy Davis and JP Eldred to the positions of senior managing director and managing director, respectively, within its Corporate Finance & Restructuring segment.